1. Home
  2. MDGL vs KEX Comparison

MDGL vs KEX Comparison

Compare MDGL & KEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • KEX
  • Stock Information
  • Founded
  • MDGL 2011
  • KEX 1921
  • Country
  • MDGL United States
  • KEX United States
  • Employees
  • MDGL N/A
  • KEX 5414
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • KEX Marine Transportation
  • Sector
  • MDGL Health Care
  • KEX Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • KEX Nasdaq
  • Market Cap
  • MDGL 6.1B
  • KEX 6.4B
  • IPO Year
  • MDGL N/A
  • KEX N/A
  • Fundamental
  • Price
  • MDGL $304.86
  • KEX $115.91
  • Analyst Decision
  • MDGL Strong Buy
  • KEX Strong Buy
  • Analyst Count
  • MDGL 9
  • KEX 2
  • Target Price
  • MDGL $420.63
  • KEX $130.00
  • AVG Volume (30 Days)
  • MDGL 305.4K
  • KEX 504.2K
  • Earning Date
  • MDGL 08-06-2025
  • KEX 07-31-2025
  • Dividend Yield
  • MDGL N/A
  • KEX N/A
  • EPS Growth
  • MDGL N/A
  • KEX 19.42
  • EPS
  • MDGL N/A
  • KEX 5.05
  • Revenue
  • MDGL $317,383,000.00
  • KEX $3,243,513,000.00
  • Revenue This Year
  • MDGL $286.17
  • KEX $4.66
  • Revenue Next Year
  • MDGL $64.17
  • KEX $5.41
  • P/E Ratio
  • MDGL N/A
  • KEX $22.76
  • Revenue Growth
  • MDGL N/A
  • KEX 2.99
  • 52 Week Low
  • MDGL $200.63
  • KEX $83.94
  • 52 Week High
  • MDGL $377.46
  • KEX $132.21
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 61.70
  • KEX 62.74
  • Support Level
  • MDGL $277.64
  • KEX $111.37
  • Resistance Level
  • MDGL $314.22
  • KEX $114.59
  • Average True Range (ATR)
  • MDGL 11.62
  • KEX 2.18
  • MACD
  • MDGL 3.11
  • KEX -0.22
  • Stochastic Oscillator
  • MDGL 82.64
  • KEX 96.04

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About KEX Kirby Corporation

Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's revenue is generated from the Marine Transportation segment.

Share on Social Networks: